18149011000001101: Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\UK product\Trade family\Neo-Naclex\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

62420401000001116 Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

111551601000001117 Neo-Naclex 2.5mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Is a	Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has specific active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Is a	Neo-Naclex	true	Inferred relationship	Existential restriction modifier
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
62420401000001116	Neo-Naclex 2.5mg tablets (Goldshield Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
111551601000001117	Neo-Naclex 2.5mg tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module